The study spanned approximately 20 weeks per patient, including an enrolment visit (V1) conducted within 8 weeks prior to Ramadan, optional intermediate visits (V2.X), and an end-of-follow-up visit (V3) 08 weeks post-Ramadan
The distinct mechanisms of action of these two drugs hold significance in the context of hyperuricemia management and gout treatment, offering clinicians versatile options to modulate uric acid levels and mitigate the risk of gout-related complications
The EVEXIAS line of Total Daily nutraceuticals are designed to help you achieve optimization and fill gaps that occur even if your diet is perfect. Soil conditions, environmental toxins, stress, and more can make it hard to get all the nutrients you need every day for optimized health
Before study initiation, the proportion of patients using a GLP-1 RA was lower than 40% in both cohorts
The timeline for any such changes would typically follow substantial weight reduction, which may take several months of GLP-1 treatment
By Winnie Liu - Last Updated: June 20, 2024 Related Posts Researchers examined how clinicians can support patient self-efficacy throughout their inflammatory bowel disease journey
